Back to Markets
BMBioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc

BMRN
Health CareBiotechnology: Pharmaceutical Preparations

$57.29

+4.55 (+8.63%)

As of 05/29/26 EDT · USD

Compare
Low: $49.26Current: $57.29High: $66.28

Key Statistics

Open

$53.50

Day High

$57.51

Day Low

$53.50

Prev. Close

$52.74

VolumeShares traded today.

5.06M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$11.07B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

41.80

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$66.28

52W LowLowest price over the past 52 weeks.

$49.26

50D MAAverage closing price over the last 50 trading days.

$54.22

200D MAAverage closing price over the last 200 trading days.

$55.83

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+5.9%

1M

+5.7%

6M

+1.8%

YTD

-3.6%

1Y

-1.3%

About

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).

Company Facts

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade BMRN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.